InflaRx NV (IFRX)
2.05
-0.05
(-2.38%)
USD |
NASDAQ |
Aug 24, 16:00
2.04
-0.01
(-0.49%)
After-Hours: 20:00
InflaRx Price to Book Value : 1.808 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.808 |
| August 21, 2026 | 1.852 |
| August 20, 2026 | 1.781 |
| August 19, 2026 | 1.869 |
| August 18, 2026 | 1.922 |
| August 17, 2026 | 1.825 |
| August 14, 2026 | 1.799 |
| August 13, 2026 | 1.772 |
| August 12, 2026 | 1.772 |
| August 11, 2026 | 1.764 |
| August 10, 2026 | 1.728 |
| August 07, 2026 | 1.622 |
| August 06, 2026 | 1.517 |
| August 05, 2026 | 1.561 |
| August 04, 2026 | 1.570 |
| August 03, 2026 | 1.543 |
| July 31, 2026 | 1.499 |
| July 30, 2026 | 1.517 |
| July 29, 2026 | 1.455 |
| July 28, 2026 | 1.490 |
| July 27, 2026 | 1.499 |
| July 24, 2026 | 1.534 |
| July 23, 2026 | 1.525 |
| July 22, 2026 | 1.587 |
| July 21, 2026 | 1.596 |
| Date | Value |
|---|---|
| July 20, 2026 | 1.605 |
| July 17, 2026 | 1.636 |
| July 16, 2026 | 1.684 |
| July 15, 2026 | 1.781 |
| July 14, 2026 | 1.772 |
| July 13, 2026 | 1.816 |
| July 10, 2026 | 1.808 |
| July 09, 2026 | 1.816 |
| July 08, 2026 | 1.905 |
| July 07, 2026 | 1.869 |
| July 06, 2026 | 1.860 |
| July 02, 2026 | 1.975 |
| July 01, 2026 | 2.054 |
| June 30, 2026 | 1.975 |
| June 29, 2026 | 3.878 |
| June 26, 2026 | 3.266 |
| June 25, 2026 | 3.164 |
| June 24, 2026 | 3.283 |
| June 23, 2026 | 3.283 |
| June 22, 2026 | 3.232 |
| June 18, 2026 | 3.078 |
| June 17, 2026 | 3.096 |
| June 16, 2026 | 2.721 |
| June 15, 2026 | 2.755 |
| June 12, 2026 | 2.721 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| MediGene AG | -- |
| BioNTech SE | 1.396 |
| Immatics NV | 2.600 |
| Beam Therapeutics, Inc. | 2.741 |
| Kymera Therapeutics, Inc. | 6.64 |
Price to Book Value Related Metrics
| PS Ratio | 2300.60 |
| Price | 2.05 |
| Earnings Yield | -31.63% |
| Market Cap | 302.10M |